SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 263 filers reported holding SHOCKWAVE MED INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,773,000 | -41.7% | 219,853 | -16.4% | 0.06% | -36.0% |
| Q2 2023 | $75,089,000 | -26.5% | 263,092 | -44.2% | 0.09% | -28.9% |
| Q1 2023 | $102,210,000 | -34.2% | 471,383 | -37.6% | 0.12% | -34.2% |
| Q4 2022 | $155,443,000 | -42.1% | 756,008 | -21.6% | 0.18% | -44.1% |
| Q3 2022 | $268,436,000 | +25.7% | 964,809 | -13.6% | 0.33% | +37.1% |
| Q2 2022 | $213,563,000 | +16.4% | 1,117,137 | +26.3% | 0.24% | +71.4% |
| Q1 2022 | $183,424,000 | +90.0% | 884,567 | +63.4% | 0.14% | +75.0% |
| Q4 2021 | $96,552,000 | -5.4% | 541,423 | +9.2% | 0.08% | -8.0% |
| Q3 2021 | $102,090,000 | -14.0% | 495,870 | -20.8% | 0.09% | -11.2% |
| Q2 2021 | $118,775,000 | +41.5% | 626,022 | -2.9% | 0.10% | -17.6% |
| Q1 2021 | $83,952,000 | +18.3% | 644,498 | -5.8% | 0.12% | +14.4% |
| Q4 2020 | $70,971,000 | +64.9% | 684,258 | +20.5% | 0.10% | +42.5% |
| Q3 2020 | $43,042,000 | +63.0% | 567,848 | +1.9% | 0.07% | +62.2% |
| Q2 2020 | $26,404,000 | – | 557,401 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |